Egetis Therapeutics

Major Shareholding Notification • Nov 1, 2023

Issuer Egetis Therapeutics AB (publ)

Holder

Flerie Invest AB

Instrument

Aktier SE0003815604
13,844,458
13,844,458
Reason for major shareholding notification Corporate action
31/10/2023
5 %
5 %
13,844,458
13,844,458
0
4.73199 %
4.73199 %
0 %

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares	4.73199 %	13,844,458
Instruments - FITA Ch. 4, section 2, first paragraph, line 2
Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled
- Cash settled
Total	4.73199 %	13,844,458
Group total holdings
Voting rights 13,844,458
Percentage of voting rights 4.73199
Published
01/11/2023 09:13
Contact
Name Cecilia Schéele
Phone 0706006856	Email cecilia@flerie.com
CLOSE PRINT

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25